Bridgewater, New Jersey
United States
7
2026-04-30
2
2025-06-03
These are the the leading inventors for applications assigned to Synthorx, Inc.:
Synthorx, Inc. based in Bridgewater, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
IMMUNO ONCOLOGY COMBINATION THERAPY WITH IL-2 CONJUGATES AND ANTI-EGFR ANTIBODIES
#2 | 2025-10-23CYTOKINE CONJUGATES FOR THE TREATMENT OF AUTOIMMUNE DISEASES
#3 | 2025-10-23CYTOKINE CONJUGATES FOR THE TREATMENT OF PROLIFERATIVE AND INFECTIOUS DISEASES
#4 | 2025-08-28INCORPORATION OF UNNATURAL NUCLEOTIDES AND METHODS THEREOF
#5 | 2025-03-13INCORPORATION OF UNNATURAL NUCLEOTIDES AND METHODS THEREOF
#6 | 2024-03-14 ✅ Patent 12,318,431 granted on 2025-06-03Cytokine conjugates for the treatment of proliferative and infectious diseases
#7 | 2023-09-28 ✅ Patent 12,377,131 granted on 2025-08-05CYTOKINE CONJUGATES FOR THE TREATMENT OF AUTOIMMUNE DISEASES
Also check out Synthorx, Inc.'s (Bridgewater, United States) applicant profile with 5 patent applications submitted.
638638 ⎘